What the company does
Alzinova AB (publ), a clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer's disease in Sweden. The company's lead product candidate is the ALZ-101, a therapeutic vaccine for the treatment of Alzheimer's disease, which has completed phase 1b clinical trial. It also develops ALZ-201, a monoclonal antibody that target and neutralize the neurotoxic forms of the peptide Aß42, called oligomers, which are considered to be the underlying cause of Alzheimer's disease; and a humanized version of ALZ-201 in patients with Alzheimer's disease that is in phase 1 clinical study. It has a research collaboration with Amsterdam …
What the weekly tape is saying
ALZ closed the latest completed week at 0.49 SEK. The 4-week return is 6.7% and the 12-week return is -19.1%. Trend Signal is inactive, Market Dynamics is 0.43. Setup signature: Risk-first tape with a 36/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.79 SEK
- Vs Trend Line
- -38.5%
- Fair Value
- 2.16 SEK
- Vs Fair Value
- -77.4%
- 52W High
- 2.28 SEK
- 52W Low
- 0.38 SEK
- Drawdown
- -78.7%
- Range Position
- 5.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- SE Healthcare
- Sector Rank
- 18 of 158
- Sector Percentile
- 89.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Biotechnology
- Tracked Peers
- 59
- 4W Rank
- 14 of 59
- Avg 1W
- 3.1%
- Avg 4W
- -1.6%
- Trend Breadth
- 30.5%
- Positive RS
- 22.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.43
- 4W MD Change
- 3569.6%
- Relative Strength
- -60.07
- 4W RS Change
- 8.0%
- Expectation
- Negative
- Probability
- 39.71%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 7.8M
- 13W Average
- 4.8M
- 52W Average
- 4.0M
- Vs 13W
- 1.6x
- Vs 52W
- 1.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 12.3%
- 52W Volatility
- 16.9%
- Upside Weeks
- 21
- Downside Weeks
- 31
- Downside Breadth
- 59.6%
- Avg Gain / Loss
- 13.2% / -10.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- SEK
- Market Cap
- 71.2M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.49 SEK | 9.0% | 0.79 SEK | 2.16 SEK | 0.43 | -60.07 | 7.8M | Off |
| 5 Jun 2026 | 0.45 SEK | 3.6% | 0.82 SEK | 2.17 SEK | 0.25 | -64.39 | 2.9M | Off |
| 29 May 2026 | 0.43 SEK | -9.0% | 0.86 SEK | 2.19 SEK | 0.19 | -66.64 | 6.3M | Off |
| 22 May 2026 | 0.47 SEK | 3.8% | 0.89 SEK | 2.20 SEK | 0.04 | -64.34 | 7.7M | Off |
| 15 May 2026 | 0.46 SEK | 13.6% | 0.92 SEK | 2.22 SEK | -0.01 | -65.33 | 4.8M | Off |
| 8 May 2026 | 0.40 SEK | -9.4% | 0.95 SEK | 2.24 SEK | -0.04 | -70.61 | 3.3M | Off |
| 1 May 2026 | 0.44 SEK | -2.5% | 1.00 SEK | 2.25 SEK | 0.14 | -68.31 | 1.7M | Off |
| 24 Apr 2026 | 0.45 SEK | -22.1% | 1.02 SEK | 2.27 SEK | 0.26 | -68.80 | 6.4M | Off |
| 17 Apr 2026 | 0.58 SEK | -1.2% | 1.04 SEK | 2.28 SEK | 0.00 | -61.93 | 2.0M | Off |
| 10 Apr 2026 | 0.59 SEK | -1.7% | 1.06 SEK | 2.30 SEK | -0.10 | -61.56 | 6.7M | Off |
| 3 Apr 2026 | 0.60 SEK | 2.0% | 1.08 SEK | 2.31 SEK | -0.26 | -59.99 | 2.9M | Off |
| 27 Mar 2026 | 0.59 SEK | -2.2% | 1.11 SEK | 2.33 SEK | -0.57 | -60.34 | 2.3M | Off |
| 20 Mar 2026 | 0.60 SEK | -34.5% | 1.13 SEK | 2.34 SEK | -0.57 | -60.66 | 7.1M | Off |
| 13 Mar 2026 | 0.92 SEK | 57.3% | 1.16 SEK | 2.36 SEK | -0.69 | -44.56 | 4.7M | Off |